-
Signature
-
/s/ Meredith Weisshaar, as Attorney-in-Fact
-
Issuer symbol
-
GTM
-
Transactions as of
-
01 Nov 2025
-
Net transactions value
-
-$168,685
-
Form type
-
4
-
Filing time
-
04 Nov 2025, 16:48:20 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| McGrane Ashley |
General Counsel and Corp Sec |
C/O ZOOMINFO TECHNOLOGIES INC.,, 330 W COLUMBIA WAY, FLOOR 8, VANCOUVER |
/s/ Meredith Weisshaar, as Attorney-in-Fact |
04 Nov 2025 |
0002057389 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
GTM |
Common Stock |
Options Exercise |
|
+23,946 |
+125% |
|
43,159 |
01 Nov 2025 |
Direct |
F1 |
| transaction |
GTM |
Common Stock |
Tax liability |
$85,777 |
-7,645 |
-18% |
$11.22 |
35,514 |
01 Nov 2025 |
Direct |
F2 |
| transaction |
GTM |
Common Stock |
Sale |
$5,763 |
-515 |
-1.5% |
$11.19 |
34,999 |
03 Nov 2025 |
Direct |
F3 |
| transaction |
GTM |
Common Stock |
Sale |
$77,145 |
-6,600 |
-19% |
$11.69 |
28,399 |
04 Nov 2025 |
Direct |
F3, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
GTM |
Restricted Stock Units |
Options Exercise |
$0 |
-23,946 |
-25% |
$0.000000 |
71,840 |
01 Nov 2025 |
Common Stock |
23,946 |
|
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: